Gimbel, Marieke E.
Chan Pin Yin, Dean R. P. P.
van den Broek, Wout W. A.
Hermanides, Renicus S.
Kauer, Floris
Tavenier, Annerieke H.
Schellings, Dirk
Brinckman, Stijn L.
The, Salem H. K.
Stoel, Martin G.
Heestermans, Ton A. C. M.
Rasoul, Saman
Emans, Mireille E.
van de Wetering, Machiel
van Bergen, Paul F. M. M.
Walhout, Ronald
Nicastia, Debby
Aksoy, Ismail
van ’t Hof, Arnoud
Knaapen, Paul
Botman, Cees-Joost
Liem, Anho
de Nooijer, Cornelis
Peper, Joyce
Kelder, Johannes C.
ten Berg, Jurriën M.
Funding for this research was provided by:
AstraZeneca
St. Antonius Ziekenhuis
Article History
Accepted: 2 August 2023
First Online: 28 September 2023
Conflict of interest
: M.E. Gimbel reports grants from AstraZeneca and from the St. Antonius research fund during the conduct of the study. A. van ’t Hof reports grants from Medtronic, Astra Zeneca and Abbott, outside the scope of the submitted work. J.M. ten Berg reports grants from AstraZeneca and from the St. Antonius research fund, personal fees from Boehringer Ingelheim, AstraZeneca, Bayer and Ferrer during the conduct of the study. D.R.P.P. Chan Pin Yin, W.W.A. van den Broek, R.S. Hermanides, F. Kauer, A.H. Tavenier, D. Schellings, S.L. Brinckman, S.H.K. The, M.G. Stoel, T.A.C.M. Heestermans, S. Rasoul, M.E. Emans, M. van de Wetering, P.F.M.M. van Bergen, R. Walhout, D. Nicastia, I. Aksoy, P. Knaapen, C.-J. Botman, A. Liem, C. de Nooijer, J. Peper and J.C. Kelder declare that they have no competing interests.